dutasteride
AssetAlso GG-745, GI 198745, NSC-740477, NSC-759880
Inhibits type 1 and type 2 5-alpha-reductase, reducing dihydrotestosterone production.
- Stage
- Approved
- Modality
- Small molecule
- Target
- SRD5A1
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Androgenetic alopecia
Approved, hitnews.co.kr, 8 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Evidence for its targets3
- Competitors2
Every asset’s record: target, stage, trials and the evidence behind it.